← All trials
NCT05686616
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 13, 2022
- Primary completion
- Apr 13, 2024
- Completion date
- Mar 3, 2025
- First posted
- Jan 17, 2023
- Last posted
- Jan 17, 2023
- Enrollment
- 72
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Sungkyunkwan UniversityLead sponsor
- Samsung Medical CenterOverall official - principal investigator
- Sungkyunkwan UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.